글로벌 투명교정장치 인비절라인, 예비 신입생 대상 올바른 치아교정 선택법 제시
글로벌 투명교정장치 ‘인비절라인(Invisalign)’이 수능을 마치고 치아교정을 고려하는 예비 대학 신입생들을 대상으로 현명한 치아교정 치료 선택 방법을 제시했다.
수능이 끝나고 나면 그동안 학업에 몰두하느라 미뤄뒀던 여러 가지 일들을 하나 둘씩 실행하기 마련이다. 이에 따라 수험생들이 치아교정을 알아보는 경우도 크게 증가한다. 인비절라인은 이때 가장 중요하게 ...
글로벌 투명교정장치 인비절라인, 예비 신입생 대상 올바른 치아교정 선택법 제시
글로벌 투명교정장치 ‘인비절라인(Invisalign)’이 수능을 마치고 치아교정을 고려하는 예비 대학 신입생들을 대상으로 현명한 치아교정 치료 선택 방법을 제시했다.
수능이 끝나고 나면 그동안 학업에 몰두하느라 미뤄뒀던 여러 가지 일들을 하나 둘씩 실행하기 마련이다. 이에 따라 수험생들이 치아교정을 알아보는 경우도 크게 증가한다. 인비절라인은 이때 가장 중요하게 ...
Rimini Street Expands Investment and Operations in Asia-Pacific
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced that it has expanded its operations in the Asia-Pacific region with the launch of its new subsidiary, Rimini Street New Zealand Limited, and the opening of its new office in Auckland to address the growing demand for Rimini Street’s premium, ultra-responsive support services in New Zealand. Rimini ...
Rimini Street Expands Investment and Operations in Asia-Pacific
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced that it has expanded its operations in the Asia-Pacific region with the launch of its new subsidiary, Rimini Street New Zealand Limited, and the opening of its new office in Auckland to address the growing demand for Rimini Street’s premium, ultra-responsive support services in New Zealand. Rimini ...
Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies
Boehringer Ingelheim and Epizyme, Inc. (Nasdaq: EPZM) today announced a new global collaboration focused on the research, development and commercialization of novel small molecule inhibitors directed toward two previously unaddressed epigenetic targets as potential therapies for people with cancer. Specifically, these targets are enzymes within the helicase and histone acetyltransferase (HAT) families that when dysregulated have been linked to the development of cancers that currently lack thera...
Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies
Boehringer Ingelheim and Epizyme, Inc. (Nasdaq: EPZM) today announced a new global collaboration focused on the research, development and commercialization of novel small molecule inhibitors directed toward two previously unaddressed epigenetic targets as potential therapies for people with cancer. Specifically, these targets are enzymes within the helicase and histone acetyltransferase (HAT) families that when dysregulated have been linked to the development of cancers that currently lack thera...
New Direct-to-home Satellite TV Bouquet for the Former Yugoslavian Countries from Telekom Srbija and SES
![]() |
New Direct-to-home Satellite TV Bouquet for the Former Yugoslavian Countries from Telekom Srbija and SES
![]() |